Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Akbar Brothers is a diversified Sri Lankan conglomerate, primarily recognized as the world's largest exporter of Ceylon tea, but with a significant presence in the healthcare and pharmaceutical sectors. Through its subsidiary, Akbar Pharmaceuticals, the company serves as a leading distributor of pharmaceutical, surgical, and diagnostic products in Sri Lanka, representing numerous global brands. Additionally, the group engages in pharmaceutical manufacturing through Lina Manufacturing, focusing on respiratory care products such as metered-dose inhalers and dry powder inhalers. The company's healthcare operations span importation, marketing, and local production to meet domestic medical needs. As a key player in the Sri Lankan healthcare infrastructure, Akbar Brothers facilitates access to essential medicines and advanced medical technology across the island.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Akbar Brothers.